Table 3.
Four high-risk patients’ characteristics
| Patient number 1 | Patient number 2 | Patient number 3 | Patient number 4 | |
|---|---|---|---|---|
| Age (years) | 50 | 30 | 51 | 53 |
| Sex | Male | Male | Male | Male |
| ECOG | 1 | 1 | 1 | 1 |
| LDH (220 U/L) | 493 | 404 | 350 | 107 |
| Extranodal site of disease | – | Bone marrow | – | Bone marrow |
| Stage | III | IV | III | IV |
| MYC expression (%) | 95 | 65 | 85 | 60 |
| BCL-2 expression (%) | 85 | 85 | 75 | 50 |
| Replase (months) | 6 | 12 | 10 | 15 |
| Survival (months) | 45 | 13 | 10 | 16 |
| NCCN-IPI score | 3 | 3 | 3 | 3 |
Abbreviations: IPI, International Prognostic Index; ECOG, Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase; NCCN, National Comprehensive Cancer Network.